E45

E45 is a leading dermatological brand and business unit that specializes in skin care products for dry and sensitive skin conditions. Originally developed in 1952 by Boots, the brand has become a household name, particularly in the United Kingdom, for the treatment of eczema, psoriasis, and dermatitis. The business was a significant part of Reckitt's consumer health portfolio for many years until its acquisition by Karo Healthcare in 2022 for £440 million. E45's product range includes clinically proven creams, lotions, and washes designed to restore and maintain the skin's natural barrier. The company operates within the consumer healthcare sector, focusing on over-the-counter dermatological solutions recommended by medical professionals. Its mission centers on providing effective, non-greasy formulations that provide long-lasting hydration and relief from skin irritation.